Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.66%
1,099.04
-7.32
-0.66%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.70%
614.59
+4.30
+0.70%
—610.29610.29614.86610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.01%
1,211.31
+0.090
+0.01%
—1,211.221,211.011,220.571,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.15%
1,753.41
+2.70
+0.15%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.89%
633.75
+5.58
+0.89%
—628.17629.38633.75629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.34%
857.49
+2.92
+0.34%
—854.57855.71859.45855.71——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.42%
217.79
+0.92
+0.42%
—216.87216.87217.76216.17——
SIXT
Technology
SIXT
Technology
SIXT
+1.40%
3,611.78
+49.84
+1.40%
—3,561.943,571.443,620.243,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.00%
903.32
+0.010
+0.00%
—903.31903.26906.56901.88——
SIXV
Health care
SIXV
Health care
SIXV
+0.27%
1,485.52
+3.98
+0.27%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.34%
2,408.20
+8.25
+0.34%
—2,399.952,404.452,412.722,398.09——
AMRX:NASDAQ
Amneal Pharmaceuticals Inc
$12.31
-0.65%
(-0.080) 1D
May 14, 11:19:22 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMRX...
Open
$12.47
High
$12.51
Low
$12.27
Mkt. cap
3.96B
Avg. vol.
1.56M
Volume
314.98K
P/E ratio
33.00
52-wk high
$15.42
52-wk low
$7.02
EPS
$0.37
Beta
1.32
Shares outstanding
319.02M
No. of employees
9K
News stories
From sources across the web
Profile
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States. Wikipedia
About Amneal Pharmaceuticals Inc
CEOChintu Patel | Chirag Patel
Employees8.7K
Founded2002
HeadquartersBridgewater, New Jersey, United States
SectorPharmaceutical industry
Websiteamneal.com
Last report
Apr 22, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$0.27 / $0.17
+59.62%beat
Revenue / Est. (USD)
722.52M / 716.78M
+0.80%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
724.51M
784.51M
814.32M
722.52M
Cost of goods sold
440.27M
490.19M
518.54M
403.95M
Cost of revenue
440.27M
490.19M
518.54M
403.95M
Research and development expenses
47.96M
63.35M
34.79M
38.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
124.27M
137.82M
146.48M
138.86M
Operating expense
172.23M
201.05M
181.28M
177.18M
Total operating expenses
612.50M
691.24M
699.82M
581.13M
Operating income
112.01M
93.27M
114.50M
141.39M
Other non operating income
-2.82M
22.04M
876.00K
3.08M
EBT including unusual items
51.71M
-5.22M
55.24M
80.18M
EBT excluding unusual items
52.34M
49.07M
57.70M
83.31M
Income tax expense
16.10M
-23.36M
5.66M
2.18M
Effective tax rate
31.14%
447.16%
10.25%
2.71%
Other operating expenses
-
-117.00K
-1.00K
-64.00K
Net income
22.42M
2.37M
35.08M
62.26M
Net profit margin
3.09%
0.30%
4.31%
8.62%
Earnings per share
0.25
0.17
0.21
0.27
Interest and investment income
-
-
-
-
Interest expense
-65.10M
-62.81M
-56.24M
-53.36M
Net interest expenses
-65.10M
-62.81M
-56.24M
-53.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
172.12M
147.34M
163.73M
184.58M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer